A study conducted at the University of Eastern Finland found distinct signatures in CD8-positive T cells in blood samples from…
Read More »TCell
Immunotherapy, treatments that reinvigorate immune cells’ anti-cancer activity or reprogram T cells to target cancer, has shown promise in treating…
Read More »Activated T cells that carry a certain marker protein on their surface are controlled by natural killer (NK) cells, another…
Read More »Targeting anti-cancer therapy to affect cancer cells but not healthy cells is challenging. For chimeric antigen receptor (CAR) T-cell immunotherapy,…
Read More »A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns…
Read More »Chimeric antigen receptor (CAR) T-cell therapy is a new way to treat cancer. It’s a living drug made from T…
Read More »